LIF Antikörper (C-Term)
-
- Target Alle LIF Antikörper anzeigen
- LIF (Leukemia Inhibitory Factor (LIF))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LIF Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogen
- Synthesized peptide derived from the C-terminal region of Human LIF.
- Isotyp
- IgG
- Top Product
- Discover our top product LIF Primärantikörper
-
anti-Leukemia Inhibitory Factor (LIF) (AA 2-201) antibody
LIF Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Leukemia Inhibitory Factor (LIF) (AA 2-201) antibodyLIF Reaktivität: Human WB, IHC, IP, ICC Wirt: Maus Monoclonal C1 unconjugated
anti-Leukemia Inhibitory Factor (LIF) (AA 72-101) antibodyLIF Reaktivität: Human WB, IHC, ELISA, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Leukemia Inhibitory Factor (LIF) (AA 72-101) antibodyLIF Reaktivität: Human, Ratte WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB21725 unconjugated
anti-Leukemia Inhibitory Factor (LIF) (AA 101-202) antibodyLIF Reaktivität: Human, Maus WB, ELISA, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Leukemia Inhibitory Factor (LIF) (AA 23-202) antibodyLIF Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Leukemia Inhibitory Factor (LIF) (C-Term) antibodyLIF Reaktivität: Human WB, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Leukemia Inhibitory Factor (LIF) (AA 23-202) antibodyLIF Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Leukemia Inhibitory Factor (LIF) (AA 25-203) antibodyLIF Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Leukemia Inhibitory Factor (LIF) (AA 1-202) antibodyLIF Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
-
- Applikationshinweise
- WB:1:500-1:2000, ELISA:1:20000,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- LIF (Leukemia Inhibitory Factor (LIF))
- Andere Bezeichnung
- LIF (LIF Produkte)
- Synonyme
- CDF antikoerper, DIA antikoerper, HILDA antikoerper, MLPLI antikoerper, LIF, interleukin 6 family cytokine antikoerper, leukemia inhibitory factor antikoerper, LIF antikoerper, Lif antikoerper
- Hintergrund
- CDF antibody, Cholinergic Differentiation Factor antibody, D factor antibody, DIA antibody, Differentiation inducing factor antibody, differentiation inhibitory activity antibody, Differentiation stimulating factor antibody, Differentiation-stimulating factor antibody, Emfilermin antibody, Hepatocyte stimulating factor III antibody, HILDA antibody, Human interleukin in DA cells antibody, Leukemia inhibitory factor antibody, LIF antibody, LIF_HUMAN antibody, Melanoma derived LPL inhibitor antibody, Melanoma-derived LPL inhibitor antibody, MLPLI antibody
- UniProt
- P15018
- Pathways
- JAK-STAT Signalweg, Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, Stem Cell Maintenance, Growth Factor Binding
-
